BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37860834)

  • 1. Prognostic Impact of Minimal Pelvic Fluid in Locally Advanced Pancreatic Cancer: A Multicenter Retrospective Study.
    Lee J; Park JS; Jeong S; Lee DH; Lim JH; Cho SG; Kwon CI; Hyun JJ; Choe JW; Cho JH; Jang SI
    Turk J Gastroenterol; 2023 Dec; 34(12):1249-1256. PubMed ID: 37860834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy.
    Choi HJ; Lee JW; Kang B; Song SY; Lee JD; Lee JH
    Yonsei Med J; 2014 Nov; 55(6):1498-506. PubMed ID: 25323885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yield of staging laparoscopy before treatment of locally advanced pancreatic cancer to detect occult metastases.
    Suker M; Koerkamp BG; Coene PP; van der Harst E; Bonsing BA; Vahrmeijer AL; Mieog JSD; Swijnenburg RJ; Dwarkasing RS; Roos D; van Eijck CHJ
    Eur J Surg Oncol; 2019 Oct; 45(10):1906-1911. PubMed ID: 31186205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer.
    Wang SL; Cao S; Sun YN; Wu R; Chi F; Tang MY; Jin XY; Chen XD
    Abdom Imaging; 2015 Oct; 40(8):3117-21. PubMed ID: 26350284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
    Peixoto RD; Speers C; McGahan CE; Renouf DJ; Schaeffer DF; Kennecke HF
    Cancer Med; 2015 Aug; 4(8):1171-7. PubMed ID: 25891650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study.
    Ogura Y; Terashima K; Nanno Y; Park S; Suga M; Takahashi D; Matsuo Y; Sulaiman NS; Tokumaru S; Okimoto T; Toyama H; Fukumoto T
    Radiat Oncol; 2022 Feb; 17(1):32. PubMed ID: 35144647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.
    Dholakia AS; Chaudhry M; Leal JP; Chang DT; Raman SP; Hacker-Prietz A; Su Z; Pai J; Oteiza KE; Griffith ME; Wahl RL; Tryggestad E; Pawlik T; Laheru DA; Wolfgang CL; Koong AC; Herman JM
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):539-46. PubMed ID: 24751410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy.
    Ren S; Zhu X; Zhang A; Li D; Zuo C; Zhang H
    Cancer Imaging; 2020 Mar; 20(1):22. PubMed ID: 32156306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy.
    Parlak C; Topkan E; Onal C; Reyhan M; Selek U
    Radiat Oncol; 2012 Mar; 7():37. PubMed ID: 22429939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The yield of chest computed tomography in patients with locally advanced pancreatic cancer.
    Suker M; Groot Koerkamp B; Nuyttens JJ; Dwarkasing RS; Homs MYV; Eskens FALM; van Eijck CHJ
    J Surg Oncol; 2020 Sep; 122(3):450-456. PubMed ID: 32378193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
    De Cuypere M; Lovinfosse P; Gennigens C; Hermesse J; Rovira R; Duch J; Goffin F; Hustinx R; Kridelka F
    Int J Gynecol Cancer; 2020 Nov; 30(11):1705-1712. PubMed ID: 33033165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?
    Bednar F; Zenati MS; Steve J; Winters S; Ocuin LM; Bahary N; Hogg ME; Zeh HJ; Zureikat AH
    Ann Surg Oncol; 2017 May; 24(5):1406-1413. PubMed ID: 27896518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
    Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).
    Vernerey D; Huguet F; Vienot A; Goldstein D; Paget-Bailly S; Van Laethem JL; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Benetkiewicz M; Louvet C; Hammel P; Bonnetain F
    Br J Cancer; 2016 Jul; 115(3):281-9. PubMed ID: 27404456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
    Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
    Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of FIGO staging defined by combining MRI and [
    Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
    Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer.
    DeWitt JM; Sandrasegaran K; O'Neil B; House MG; Zyromski NJ; Sehdev A; Perkins SM; Flynn J; McCranor L; Shahda S
    Gastrointest Endosc; 2019 Feb; 89(2):390-398. PubMed ID: 30222972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy.
    Cho WK; Yu JI; Park HC; Lim DH; Kim TH; Chie EK
    Tumori; 2021 Jun; 107(3):247-253. PubMed ID: 32646298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis.
    Wang Z; Ren ZG; Ma NY; Zhao JD; Zhang Z; Ma XJ; Long J; Xu J; Jiang GL
    Radiat Oncol; 2015 Jan; 10():14. PubMed ID: 25575617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
    He CB; Wang J; Mao YZ; Lao XM; Li SP
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.